These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
886 related articles for article (PubMed ID: 33726814)
1. Histone lactylation drives oncogenesis by facilitating m Yu J; Chai P; Xie M; Ge S; Ruan J; Fan X; Jia R Genome Biol; 2021 Mar; 22(1):85. PubMed ID: 33726814 [TBL] [Abstract][Full Text] [Related]
2. m Jia R; Chai P; Wang S; Sun B; Xu Y; Yang Y; Ge S; Jia R; Yang YG; Fan X Mol Cancer; 2019 Nov; 18(1):161. PubMed ID: 31722709 [TBL] [Abstract][Full Text] [Related]
3. The m Xu Y; He X; Wang S; Sun B; Jia R; Chai P; Li F; Yang Y; Ge S; Jia R; Yang YG; Fan X Oncogene; 2022 Feb; 41(9):1281-1297. PubMed ID: 35110680 [TBL] [Abstract][Full Text] [Related]
4. Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m Zhuang A; Gu X; Ge T; Wang S; Ge S; Chai P; Jia R; Fan X Cancer Commun (Lond); 2023 Nov; 43(11):1185-1206. PubMed ID: 37466203 [TBL] [Abstract][Full Text] [Related]
5. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928 [TBL] [Abstract][Full Text] [Related]
6. Metabolic regulation of gene expression by histone lactylation. Zhang D; Tang Z; Huang H; Zhou G; Cui C; Weng Y; Liu W; Kim S; Lee S; Perez-Neut M; Ding J; Czyz D; Hu R; Ye Z; He M; Zheng YG; Shuman HA; Dai L; Ren B; Roeder RG; Becker L; Zhao Y Nature; 2019 Oct; 574(7779):575-580. PubMed ID: 31645732 [TBL] [Abstract][Full Text] [Related]
7. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907 [TBL] [Abstract][Full Text] [Related]
8. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Li W; Zhou C; Yu L; Hou Z; Liu H; Kong L; Xu Y; He J; Lan J; Ou Q; Fang Y; Lu Z; Wu X; Pan Z; Peng J; Lin J Autophagy; 2024 Jan; 20(1):114-130. PubMed ID: 37615625 [TBL] [Abstract][Full Text] [Related]
9. m He F; Yu J; Yang J; Wang S; Zhuang A; Shi H; Gu X; Xu X; Chai P; Jia R Mol Ther; 2021 Jun; 29(6):2121-2133. PubMed ID: 33601055 [TBL] [Abstract][Full Text] [Related]
10. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
11. Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Gu X; Zhuang A; Yu J; Yang L; Ge S; Ruan J; Jia R; Fan X; Chai P Nucleic Acids Res; 2024 Mar; 52(5):2273-2289. PubMed ID: 38118002 [TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles shed by melanoma cells contain a modified form of H1.0 linker histone and H1.0 mRNA-binding proteins. Schiera G; Di Liegro CM; Puleo V; Colletta O; Fricano A; Cancemi P; Di Cara G; Di Liegro I Int J Oncol; 2016 Nov; 49(5):1807-1814. PubMed ID: 27633859 [TBL] [Abstract][Full Text] [Related]
13. YTHDF1 Promotes Cyclin B1 Translation through m Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W Cells; 2021 Jul; 10(7):. PubMed ID: 34359836 [TBL] [Abstract][Full Text] [Related]
14. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. Du C; Lv C; Feng Y; Yu S J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165 [TBL] [Abstract][Full Text] [Related]
15. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pan L; Feng F; Wu J; Fan S; Han J; Wang S; Yang L; Liu W; Wang C; Xu K Pharmacol Res; 2022 Jul; 181():106270. PubMed ID: 35605812 [TBL] [Abstract][Full Text] [Related]
16. METTL3/YTHDF2 m Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149 [TBL] [Abstract][Full Text] [Related]
17. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677 [TBL] [